Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Bowlus

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Epigenetics & Chromatin|February 3, 2019
Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancersCharles E Mordaunt, Dorothy A Kieffer, Noreene M Shibata, et al.
Hepatology Communications|May 15, 2023
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot studyChristopher L Bowlus, Bertus Eksteen, Angela C Cheung, et al.
Journal of Hepatology|March 14, 2020
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitisKris V Kowdley, Raj Vuppalanchi, Cynthia Levy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2020
Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing CholangitisPalak J Trivedi, Andrew J Muir, Cynthia Levy, et al.
Journal of Autoimmunity|June 18, 2020
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitisXing Zhou, Muchena J Kailemia, Ying Sun, et al.
Hepatology (Baltimore, Md.)|August 4, 2020
A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing CholangitisYevgeniy Gindin, Chuhan Chung, Zhaoshi Jiang, et al.
Clinical Reviews in Allergy & Immunology|December 20, 2017
The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature ReviewMingjie Yao, Leijie Wang, Patrick S C Leung, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2024
Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary CholangitisLinhua Zheng, Siyuan Tian, Chunmei Yang, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosisRuth Y Lan, Chunmei Cheng, Zhe-Xiong Lian, et al.
Clinical Reviews in Allergy & Immunology|August 13, 2016
The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive ReviewZhaoyue Wang, Li Sheng, Yue Yang, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Epigenetics & Chromatin|February 3, 2019
Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancersCharles E Mordaunt, Dorothy A Kieffer, Noreene M Shibata, et al.
Hepatology Communications|May 15, 2023
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot studyChristopher L Bowlus, Bertus Eksteen, Angela C Cheung, et al.
Journal of Hepatology|March 14, 2020
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitisKris V Kowdley, Raj Vuppalanchi, Cynthia Levy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2020
Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing CholangitisPalak J Trivedi, Andrew J Muir, Cynthia Levy, et al.
Journal of Autoimmunity|June 18, 2020
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitisXing Zhou, Muchena J Kailemia, Ying Sun, et al.
Hepatology (Baltimore, Md.)|August 4, 2020
A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing CholangitisYevgeniy Gindin, Chuhan Chung, Zhaoshi Jiang, et al.
Clinical Reviews in Allergy & Immunology|December 20, 2017
The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature ReviewMingjie Yao, Leijie Wang, Patrick S C Leung, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2024
Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary CholangitisLinhua Zheng, Siyuan Tian, Chunmei Yang, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosisRuth Y Lan, Chunmei Cheng, Zhe-Xiong Lian, et al.
Clinical Reviews in Allergy & Immunology|August 13, 2016
The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive ReviewZhaoyue Wang, Li Sheng, Yue Yang, et al.
Pageof 19